Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.carrev.2020.05.027 http://scihub22266oqcxt.onion/10.1016/j.carrev.2020.05.027 32471712!7241397!32471712     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32471712&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cardiovasc+Revasc+Med 2020 ; 21 (8): 1024-1029 Nephropedia Template TP {{tp|p=32471712|t=2020. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic |pdf=|usr=}}{{32471712}} gab.com Text Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic JO: Cardiovasc Revasc Med http://www.kidney.de/pget.php?&tw=1&pmid=32471712 #FOAvip The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy. Twit Text FOAVip Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic ????Cardiovasc Revasc Med http://www.kidney.de/pget.php?&tw=1&pmid=32471712 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32471712 #FOAvip English Wikipedia <ref>{{Cite pmid|32471712}}</ref> Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic #MMPMID32471712 Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R Cardiovasc Revasc Med 2020[Aug]; 21 (8): 1024-1029 PMID32471712show ga The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy. |*Betacoronavirus[MESH] |*Pandemics[MESH] |COVID-19[MESH] |Comorbidity[MESH] |Coronary Angiography[MESH] |Coronavirus Infections/*epidemiology[MESH] |Humans[MESH] |Percutaneous Coronary Intervention/*methods[MESH] |Pneumonia, Viral/*epidemiology[MESH] |SARS-CoV-2[MESH]Treatment of ST-Segment Elevation Myocardial Infarction During COVID-1(epmc).pdf DeepDyve Pubget Overpricing